Algorithm of appointment (examination; consultation) of patients under follow-up care by a general practitioner

A unified algorithm for appointment (examination; consultation) of patients under follow-up care by a general practitioner has been developed.

In order to create the algorithm; we analyzed and systematized data on managing and conducting events within the appointment (examination; consultation) of outpatients by a general practitioner; contained in regulatory legal acts of the Russian Federation; clinical guidelines; scientific and methodological literature. Analytical and comparative methods; as well as the method of content analysis were used. The accumulation; adjustment; and systematization of the obtained results were carried out in Microsoft Office Excel 2016 spreadsheets.

The algorithm for a dispensary appointment (examination; consultation) by a general practitioner consists of 9 following modules: patient intake; physical examination; assessing the achievement of health targets; assessing the risk of adverse events; assessing the results of consultations with specialists; establishing or clarifying the diagnosis of a disease (condition); prescribing preventive; diagnostic; therapeutic; and rehabilitation measures for medical reasons; informing the patient about the appointment (examination; consultation); preparing medical documentation.

The developed algorithm contains systematized information on the activities within appointment (examination; consultation) of patients under follow-up care by a general practitioner; which will allow for the full implementation of prevention and timely detection of complications or exacerbations of diseases (conditions); treatment adjustment; reduction in the number of urgent hospitalizations; implementation of medical rehabilitation; therapeutic and preventive and health resort treatment.

1. Shchukin YuV, Dyachkov VA, Ryabov AE. Propaedeutics of internal diseases: methods of patient examination: a textbook for students studying in the specialties: 060101 65 — General Medicine, 060103 65 — Pediatrics. Samara: OOO "Izdatelstvo As Gard", 2012. 280 с. (In Russ.) ISBN: 978-5-4259-0153-8.

2. Shchukin YuV, Dyachkov VA, Ryabov AE, et al. Propaedeutics of internal diseases: a teaching aid for students of the faculty of higher nursing education of medical universities. Samara: OOO "Tipo¬grafiya", 2010. 336 p. (In Russ.) ISBN: 978-5-91715-065-9.

3. Gilyarevsky SA. Propaedeutics of internal diseases. 2nd ed., corrected and supplemented. М.: Medicine, 1965. 346 p. (In Russ.)

4. Belenkov YuN, Oganov RG. Guide to outpatient cardiology. Moscow: GEOTAR-Media, 2007. 398 p. (In Russ.) ISBN: 5-9704-0308-3.

5. Myasnikov AL. Propaedeutics of internal diseases. Moscow: MEDGIS, 1956. 627 p. (In Russ.)

6. Zegglin R. Differential diagnostics of internal diseases. Moscow: Medicine, 1965. 796 p. (In Russ.)

7. Bates B. Encyclopedia of clinical examination of the patient: Trans-lated from English. Moscow: GEOTAR MEDITSINA, 1998. 704 p. (In Russ.) ISBN: 5-88816-019-9.

8. Ivashkin VT, Drapkina OM. Propaedeutics of internal diseases. Moscow: Special publishing house of medical books, 2014. 408 p. (In Russ.) ISBN: 978-5-91894-032-7.

9. Prozorova GG, Chernov AV. Dispensary observation and reha-bilitation after COVID-19 infection. Voronezh: Publishing and printing center "Scientific Book", 2021. 276 p. (In Russ.) ISBN: 978-5-4446-1520-1.

10. Maev IV, Shestakov VA, Samsonov AA, et al. Propaedeutics of internal diseases. Moscow: Publishing Center "Academy", 2012. 368 p. (In Russ.) ISBN: 978-5-7695-9322-2.

11. Drapkina OM, Maksimov SA, Shalnova SA, et al. Prevalence of smoking and its changes over time in Russia: data from the ESSE-RF study. Cardiovascular Therapy and Prevention. 2023; 22(8S):3790. (In Russ.) doi:10.15829/1728-8800-2023-3790.

12. Kotova MB, Maksimov SA, Shalnova SA, et al. Levels and types of physical activity in Russia according to the ESSE-RF study: is there a trace of the COVID-19 pandemic? Cardiovascular Therapy and Pre¬ven-tion. 2023;22(8S):3787. (In Russ.) doi:10.15829/1728-8800-2023-3787.

13. Maksimov SA, Shalnova SA, Balanova YuA, et al. Alcohol con-sumption patterns in Russia according to the ESSE-RF study: is there a COVID-19 trace? Cardiovascular Therapy and Prevention. 2023;22(8S):3786. (In Russ.) doi:10.15829/1728-8800-2023-3786.

14. Balanova YuA, Drapkina OM, Kutsenko VA, et al. Obesity in the Russian population during the COVID-19 pandemic and associated factors. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023;22(8S):3793. (In Russ.) doi:10.15829/1728-8800-2023-3793.

15. Balanova YuA, Shalnova SA, Imaeva AE, et al. Risk stratification of type 2 diabetes in the Russian population depending on FINDRISC category: results of prospective follow-up. Cardiovascular Therapy and Prevention. 2024;23(6):3967. (In Russ.) doi:10.15829/1728-8800-2024-3967.

16. Balanova YuA, Shalnova SA, Imaeva AE, et al. Prediabetes: prevalence, associations with cardiovascular risk factors and contribution to survival in the Russian population. Cardiovascular Therapy and Prevention. 2024;23(5):4022. (In Russ.) doi:10.15829/1728-8800-2024-4022.

17. Drapkina OM, Imaeva AE, Kutsenko VA, et al. Dyslipidemia in the Russian Federation: population data, associations with risk factors. Cardiovascular Therapy and Prevention. 2023;22(8S):3791. (In Russ.) doi:10.15829/1728-8800-2023-3791.

18. Balanova YuA, Drapkina OM, Kutsenko VA, et al. Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023;22(8S):3785. (In Russ.) doi:10.15829/1728-8800-2023-3785.

19. Gambaryan MG, Lusnikov VP, Kontsevaya AV, et al. Organising medical support for tobacco cessation and its relationship with smoking prevalence across the subjects of the Russian Federation. Russian Journal of Preventive Medicine. 2024;27(10):7-14. (In Russ.) doi:10.17116/profmed2024271017.

20. Kulikova MS, Kalinina AM, Drozdova LYu, et al. Detection of overweight and behavioral risk factors for its development within screening. Russian Journal of Preventive Medicine. 2024;27(9):37-43. (In Russ.) doi:10.17116/profmed20242709137.

21. Drapkina OM, Begrambekova YuL, Orlov DO, et al. Determination of factors influencing the desire and possibilities of prevention of inactivity and other behavioral risk factors by primary care physicians (REFLECTION). The results of a one-time survey. Kardiologiia. 2022;62(5):9-17. (In Russ.) doi:10.18087/cardio.2022.5.n2022.

22. Drapkina OM, Drozdova LYu, Yakimova YuV, et al. Methodological recommendations "Standard operating procedure for conducting preventive medical examination and medical examination of certain groups of the adult population". Moscow: FSBI "National Medical Research Center for Therapy and Preventive Medicine" of the Ministry of Healthсare of the Russian Federation, 2022. 74 p. (In Russ.)

23. Drapkina OM, Drozdova LYu, Kalinina AM, et al. Organization of preventive medical examination and medical examination of certain groups of the adult population. Methodological recommendations. 2nd edition. Moscow: FSBI "National Medical Research Center for Therapy and Preventive Medicine" of the Ministry of Healthсare of the Russian Federation, 2020. 232 p. (In Russ.) ISBN: 978-5-6043991-1-8.

24. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines. Cardiovascular Therapy and Prevention. 2024; 23(3):3996. (In Russ.) doi:10.15829/1728-8800-2024-3996.

25. Primary health care, public health and health organization. Hand¬book of concepts and terms. Comp. Kalinina AM, Savchenko DO, Voshev DV, et al. M.: ROPNIZ, LLC "SiliceaPolygraph", 2023. p. 76. (In Russ.) ISBN: 978-5-6050061-1-4. doi:10.15829/ROPNIZ-k1-2023.

26. Boytsov SА, Loukianov MM, Yakushin SS, et al. The study "Register of patients after acute stroke (REGION)". Part 2. Оutpatient prospective register of patients after acute stroke (according to the results of the pilot phase of the study). Rational Pharmacotherapy in Cardiology. 2017;13(1):4-17. (In Russ.) doi:10.20996/1819-6446-2017-13-1-4-17.

27. Boytsov SA, Luk’yanov MM, Yakushin SS, et al. Cardiovascular diseases registry (RECVAZA): diagnostics, concomitant cardiovascular pathology, comorbidities and treatment in the real outpatient-polyclinic practice. Cardiovascular Therapy and Prevention. 2014;13(6):44-50. (In Russ.) doi:10.15829/1728-8800-2014-6-3-8.

28. Yakusevich VV, Pozdnyakova EM, Yakusevich VV, et al. An outpatient with atrial fibrillation: key features. the first data of REKVAZA FP — Yaroslavl register. Rational Pharmacotherapy in Cardiology. 2015;11(2):149-52. (In Russ.) doi:10.20996/1819-6446-2015-11-2-149-152.

29. Loukianov MM, Gomova TA, Savishceva AA, et al. Registry of the multifaceted medical center (SOFIT): the main tasks, development, and the first results. Russian Journal of Preventive Medicine. 2023;26(6):46 54. (In Russ.) doi:10.17116/profmed20232606146.

30. Voronina VP, Zagrebelny A, Lukina YuV, et al. Long-term prognosis of life in patients with cerebrovascular accident: the role of diabetes mellitus (according to the REGION-M registry outpatient follow-up phase). Rational Pharmacotherapy in Cardiology. 2024;20(3):316-21. (In Russ.) doi:10.20996/1819-6446-2024-3039.

31. Drapkina OM, Kontsevaya AV, Kalinina AM. Organizational aspects of outpatient management of comorbid patients. M.: 2020. 144 p. (In Russ.) ISBN: 978-5-604218-2-7.

32. Nikolaev NA, Martynov AI, Skirdenko YuP, et al. International declaration of adherence to treatment 2023 ("Omsk declaration"): presentation for russian readers. Medical News of North Caucasus. 2024;19(1):1-9. (In Russ.) doi:10.14300/mnnc.2024.19001.

33. Lukina YuV, Kutishenko NP, Martsevich SYu, et al. Questionnaires and scores for assessing medication adherence — advantages and disadvantages of the diagnostic method in research and actual clinical practice. Cardiovascular Therapy and Prevention. 2020;19(3):2562. (In Russ.) doi:10.15829/1728-8800-2020-2562.

34. Lukina YuV, Kutishenko NP, Martsevich SYu, et al. Novel approaches to the comprehensive assessment of the quality and adherence to pharmacotherapy and its use in cardiovascular patients. Cardiovascular Therapy and Prevention. 2023;22(1):3522. (In Russ.) doi:10.15829/1728-8800-2023-3522.

35. Lukina YuV, Kutishenko P, Martsevich SYu, et al. The questionnaire survey method in medicine on the example of treatment adherence scales. Rational Pharmacotherapy in Cardiology. 2021;17(4):576-83. (In Russ.) doi:10.20996/1819-6446-2021-08-02.

36. Nikolaev NA, Martynov AI, Skirdenko YuP, et al. Adherence to treatment. Russian national guidelines. Moscow: Publishing House of the Academy of Natural Sciences, 2022. 224 p. (In Russ.) ISBN: 978-5-91327-746-6. doi:10.17513/np.541.

37. Hovstadius B, Hovstadius K, Astrand B, et al. Increasing poly-pharmacy — an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol. 2010;10(16). doi:10.1186/1472-6904-10-16.

38. Shepel RN, Demko VV, Goncharov MV, et al. Analysis of question-naires from the perspective of hospitalization risk prediction. Systematic review. Cardiovascular Therapy and Prevention. 2024;23(5):4026. (In Russ.) doi:10.15829/1728-8800-2024-4026.

39. Martsevich SYu, Kutishenko NP, Lukina YuV, et al. Polypharmacy: definition, impact on outcomes, need for correction. Rational Phar¬ma-cotherapy in Cardiology. 2023;19(3):254-63. (In Russ.) doi:10.20996/1819-6446-2023-2924.

40. Sychev D, Sosnovsky E, Otdelenov V. Medical appropriateness index as a method for polypharmacy control. Clin Pharmacol Ther. 2016;25(3):79-82. (In Russ.)

41. Beregovykh VV, Panteleev VI, Shimanovsky NL. Polypharmacotherapy: the use of artificial intelligence to reduce risk of adverse drug reactions (review). Annals of the Russian academy of medical sciences. 2024;79(4):346-52. (In Russ.) doi:10.15690/vramn17965.

42. Samorodskaya IV, Shepel RN, Klyuchnikov IV, et al. Possibilities and reserves of using electronic medical records data in health information systems on the example of assessing the causes of visits to outpatient clinics and death in patients with acute forms of coronary artery disease. Cardiovascular Therapy and Prevention. 2024;23(12):4273. (In Russ.) doi:10.15829/1728-8800-2024-4273.

43. Gorbunov VM, Smirnova MI, Kurekhyan AS, et al. Evaluation of office and ambulatory blood pressure in the practice of a primary care physician. Guidelines. Cardiovascular Therapy and Prevention. 2023;22(7):3666. (In Russ.) doi:10.15829/1728-8800-2023-3666.

44. Tregubov AV, Tregubova AA, Alekseeva IV, et al. Experience of using the SCORE and SCORE2 scales to assess the risk of cardiovascular complications in residents of the Russian Federation. Atherosclerosis and Dyslipidemia. 2022;3(48)41-7. (In Russ.) doi:10.34687/2219-8202.JAD.2022.03.0005.

45. Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124. doi:10.1136/bmj.d124.

46. Lip GY, Frison L, Halperin JL, et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011;57(2):173-80. doi:10.1016/j.jacc.2010.09.024.

47. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi:10.1016/0021-9681(87)90171-8.

48. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42(1):S100-7. doi:10.1016/j.jhep.2004.11.015.

49. Mustafina SV, Rymar OD, Sazonova OV, et al. Validation of the Finnish diabetes risk score (FINDRISC) for the Caucasian population of Siberia. Diabetes mellitus. 2016;19(2):113-8. (In Russ.) doi:10.14341/DM200418-10.

50. Astanina SYu, Kalinina AM, Shepel RN, et al. Communication skills of a local general practitioner in conducting preventive counseling (methodological aspect). Cardiovascular Therapy and Prevention. 2023;22(1S):3559. (In Russ.) doi:10.15829/1728-8800-2023-3559.

51. Astanina SYu, Kalinina AM, Shepel RN, et al. Methodological features of the development of the communicative competence of local general practitioner in preventive counseling. Cardiovascular Therapy and Prevention. 2023;22(2S):3648. (In Russ.) doi:10.15829/1728-8800-2023-3648.

52. Drapkina OM, Demko VV, Kalinina AM, et al. Preventive counseling of patients with risk factors for noncommunicable diseases in clinical practice. Analytical review. Cardiovascular Therapy and Prevention. 2024;23(12):4154. (In Russ.) doi:10.15829/1728-8800-2024-4154.

53. Drapkina OM, Briko NI, Kostinov MP, et al. Immunization of adults. Methodological recommendations. Moscow: FSBI "National Medical Research Center for Therapy and Preventive Medicine" of the Ministry of Healthсare of the Russian Federation, 2020. 248 p. (In Russ.) ISBN: 978-5-6043991-3-2.

54. Kamkin EG, Karakulina EV, Bakulin PS, et al. Methodological rеcommendations "Organization of registration for an appointment with a doctor, including through a single portal of state and municipal services and single regional call centers (third edition, revised and supplemented)". Moscow, 2023. (In Russ.)